CD02_OpenLabel Investigational Site — Palm Springs, California

CD02_OpenLabel Investigational Site is a clinical research site located in Palm Springs, California, United States 92262.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

CD02_OpenLabel Investigational Site has participated in 1 clinical trials.

Therapeutic areas: HIV-1-infection.

Sponsors: CytoDyn, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palm Springs

Browse all research sites in California · View every site in Palm Springs

• Desert Hospital Comprehensive Cancer Center
• Desert Regional Medical Center
• Palmtree Clinical Research
• Research Site
• GSK Investigational Site
• Desert Oasis Healthcare Medical Group
• Desert Oasis Hlthcr Med Group
• Desert Regional Medical Center Comprehensive Cancer Center
• Novo Nordisk Investigational Site
• Comprehensive Cancer Center
• Pfizer Investigational Site
• Southern California Desert Retina Consultants, MC

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CD02_OpenLabel Investigational Site?

CD02_OpenLabel Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CD02_OpenLabel Investigational Site conducted?

CD02_OpenLabel Investigational Site has 1 clinical trials on record. Their work covers HIV-1-infection.

Is CD02_OpenLabel Investigational Site accredited by Crixeo Clinical Trials?

CD02_OpenLabel Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CD02_OpenLabel Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.